John Imeson

6.7k total citations · 2 hit papers
48 papers, 5.1k citations indexed

About

John Imeson is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Neurology. According to data from OpenAlex, John Imeson has authored 48 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 12 papers in Neurology. Recurrent topics in John Imeson's work include Neuroblastoma Research and Treatments (11 papers), Renal and related cancers (7 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). John Imeson is often cited by papers focused on Neuroblastoma Research and Treatments (11 papers), Renal and related cancers (7 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). John Imeson collaborates with scholars based in United Kingdom, United States and Australia. John Imeson's co-authors include Yvonne Stirling, Andy Haines, T W Meade, T W Meade, Simon G. Thompson, George J. Miller, Ranjan Chakrabarti, W. R. S. North, M Brozović and Ian Lewis and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

John Imeson

48 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY

1986 1.6k citations Andy Haines, John Imeson et al. profile →
EFFECTS OF CHANGES IN SMOKING AND OTHER CHARACTERISTICS ON CLOTTING FACTORS AND THE RISK OF ISCHAEMIC HEART DISEASE

1987 346 citations T W Meade, John Imeson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Imeson United Kingdom	32	1.9k	1.0k	999	979	925	48	5.1k
Barney J. Stern United States	47	3.9k 2.0×	783 0.8×	1.3k 1.4×	2.7k 2.8×	915 1.0×	114	8.2k
Ralf Junker Germany	37	479 0.2×	526 0.5×	1.1k 1.1×	615 0.6×	1.1k 1.2×	93	4.7k
Martin Soubrier France	42	516 0.3×	656 0.6×	500 0.5×	743 0.8×	1.3k 1.4×	300	6.7k
Hideki Hirakata Japan	43	663 0.3×	660 0.6×	645 0.6×	145 0.1×	648 0.7×	161	5.8k
Robert Birch United States	33	959 0.5×	1.0k 1.0×	112 0.1×	660 0.7×	1.8k 1.9×	107	5.0k
Vincent Brandenburg Germany	48	976 0.5×	749 0.7×	987 1.0×	121 0.1×	1.0k 1.1×	151	6.4k
David G. Sherman United States	30	1.6k 0.8×	298 0.3×	2.3k 2.3×	1.1k 1.1×	574 0.6×	75	5.2k
О. Л. Барбараш Russia	25	2.4k 1.3×	2.4k 2.3×	1.6k 1.6×	186 0.2×	972 1.1×	714	6.3k
Laura M. Dember United States	40	1.3k 0.7×	3.4k 3.4×	465 0.5×	392 0.4×	902 1.0×	122	6.3k
Thomas L. Nickolas United States	47	546 0.3×	825 0.8×	287 0.3×	222 0.2×	1.3k 1.4×	107	6.5k

Countries citing papers authored by John Imeson

Since Specialization

Citations

This map shows the geographic impact of John Imeson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Imeson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Imeson more than expected).

Fields of papers citing papers by John Imeson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Imeson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Imeson. The network helps show where John Imeson may publish in the future.

Co-authorship network of co-authors of John Imeson

This figure shows the co-authorship network connecting the top 25 collaborators of John Imeson. A scholar is included among the top collaborators of John Imeson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Imeson. John Imeson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pearson, Andrew D.J., CR Pinkerton, Ian Lewis, et al.. (2008). High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial. The Lancet Oncology. 9(3). 247–256. 252 indexed citations

Mitchell, Christopher, Kathy Pritchard‐Jones, R S Shannon, et al.. (2006). Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms’ tumour: Results of a randomised trial (UKW3) by the UK Children’s Cancer Study Group. European Journal of Cancer. 42(15). 2554–2562. 111 indexed citations

Atra, Ayad, CR Pinkerton, Éric Bouffet, et al.. (2004). Acute neurotoxicity in children with advanced stage B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukaemia treated with the United Kingdom children cancer study group 9002/9003 protocols. European Journal of Cancer. 40(9). 1346–1350. 15 indexed citations

Atra, Ayad, et al.. (2002). ChlVPP chemotherapy in children with stage IV Hodgkin's disease: results of the UKCCSG HD 8201 and HD 9201 studies. British Journal of Haematology. 119(3). 647–651. 6 indexed citations

Atra, Ayad, Mary Gerrard, Rachel Hobson, et al.. (2001). Outcome of relapsed or refractory childhood B‐cell acute lymphoblastic leukaemia and B‐cell non‐Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols. British Journal of Haematology. 112(4). 965–968. 38 indexed citations

Cotterill, Simon, A. D. J. Pearson, Jon Pritchard, et al.. (2000). Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982–1992. European Journal of Cancer. 36(7). 901–908. 123 indexed citations

Mitchell, Christopher, P. Morris Jones, Anna Kelsey, et al.. (2000). The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study. British Journal of Cancer. 83(5). 602–608. 90 indexed citations

Atra, Ayad, John Imeson, Rachel Hobson, et al.. (2000). Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol. British Journal of Cancer. 82(8). 1396–1402. 51 indexed citations

Kohler, J A, John Imeson, Caroline Ellershaw, & S O Lie. (2000). A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy. British Journal of Cancer. 83(9). 1124–1127. 53 indexed citations

10.

Boddy, Alan V., CR Pinkerton, Ian Lewis, et al.. (1998). Validation of pharmacologically-guided dosing of carboplatin in paediatric patients. British Journal of Cancer. 78. 9–9. 2 indexed citations

11.

Mann, Jillian R., F. Raafat, Katie Robinson, et al.. (1998). UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours—carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. Medical and Pediatric Oncology. 30(4). 217–227. 39 indexed citations

12.

Lowis, Stephen P., A.B.M. Foot, Mary Gerrard, et al.. (1998). Central nervous system metastasis in Wilms' tumor. Cancer. 83(9). 2023–2029. 19 indexed citations

13.

Pritchard, Jon, John Imeson, Janet M. Barnes, et al.. (1995). Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.. Journal of Clinical Oncology. 13(1). 124–133. 93 indexed citations

14.

Imeson, John, et al.. (1993). Improvement in survival for Ewing's sarcoma by substitution of Ifosfamide for Cyclophosphamide. Journal of Pediatric Hematology/Oncology. 6 indexed citations

15.

Kelleher, Cecily, K.A. Mitropoulos, John Imeson, et al.. (1992). Hageman factor and risk of myocardial infarction in middle-aged men. Atherosclerosis. 97(1). 67–73. 21 indexed citations

16.

Meade, T W, Sandra Dyer, David Howarth, John Imeson, & Yvonne Stirling. (1990). Antithrombin III and procoagulant activity: sex differences and effects of the menopause. British Journal of Haematology. 74(1). 77–81. 90 indexed citations

17.

Imeson, John, Andy Haines, & T W Meade. (1989). Skinfold thickness, body mass index and ischaemic heart disease.. Journal of Epidemiology & Community Health. 43(3). 223–227. 18 indexed citations

18.

Haines, Andy, John Imeson, & T W Meade. (1987). Phobic anxiety and ischaemic heart disease.. BMJ. 295(6593). 297–299. 215 indexed citations

19.

Greenberg, Gillian, John Imeson, Simon G. Thompson, & T W Meade. (1985). Blood pressure and the menstrual cycle. BJOG An International Journal of Obstetrics & Gynaecology. 92(10). 1010–1014. 35 indexed citations

20.

Haines, Andy, John Imeson, & T W Meade. (1980). Psychoneurotic profiles of smokers and non-smokers.. BMJ. 280(6229). 1422–1422. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact